Comparison of Various Ultrasound-Based Malignant Risk Stratification Systems on an Occasion for Assessing Thyroid Nodules in Hashimoto’s Thyroiditis

References

• Singh ON, Iniguez-Ariza NM, Castro MR. Thyroid nodules: diagnostic evaluation based on thyroid cancer risk assessment. BMJ. 2020;368:l6670. doi:10.1136/bmj.l6670
   PubMedGoogle Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133. doi:10.1089/thy.2015.0020
   PubMed Web of Science ®Google Scholar
• Shin JH, Baek JH, Chung J, et al. Ultrasonography diagnosis and imaging-based management of thyroid nodules: revised Korean Society of thyroid radiology consensus statement and recommendations. Korean J Radiol. 2016;17(3):370–395. doi:10.3348/kjr.2016.17.3.370
   PubMed Web of Science ®Google Scholar
• Tessler FN, Middleton WD, Grant EG, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. 2017;14(5):587–595. doi:10.1016/j.jacr.2017.01.046
   PubMed Web of Science ®Google Scholar
• Won JH, Lee JY, Hong HS, et al. Thyroid nodules and cancer in children and adolescents affected by Hashimoto’s thyroiditis. Br J Radiol. 2018;91(1087):20180014. doi:10.1259/bjr.20180014
   PubMed Web of Science ®Google Scholar
• Vita R, Ieni A, Tuccari G, et al. The increasing prevalence of chronic lymphocytic thyroiditis in papillary microcarcinoma. Rev Endocr Metab Disord. 2018;19(4):301–309. doi:10.1007/s11154-018-9474-z
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim Y, Choi JW, et al. The association between papillary thyroid carcinoma and histologically proven Hashimoto’s thyroiditis: a meta-analysis. Eur J Endocrinol. 2013;168(3):343–349. doi:10.1530/EJE-12-0903
   PubMed Web of Science ®Google Scholar
• Liu Y, Lv H, Zhang S, et al. The impact of coexistent Hashimoto’s thyroiditis on central compartment lymph node metastasis in papillary thyroid carcinoma. Front Endocrinol. 2021;12:772071. doi:10.3389/fendo.2021.772071
   PubMed Web of Science ®Google Scholar
• Baser H, Ozdemir D, Cuhaci N, et al. Hashimoto’s thyroiditis does not affect ultrasonographical, cytological, and histopathological features in patients with papillary thyroid carcinoma. Endocr Pathol. 2015;26(4):356–364. doi:10.1007/s12022-015-9401-8
   PubMed Web of Science ®Google Scholar
• Osborne D, Choudhary R, Vyas A, et al. Hashimoto’s thyroiditis effects on papillary thyroid carcinoma outcomes: a systematic review. Cureus. 2022;14(8):e28054. doi:10.7759/cureus.28054
   PubMed Web of Science ®Google Scholar
• Yu Z, Yu Y, Wan Y, et al. Iodine intake level and incidence of thyroid disease in adults in Shaanxi province: a cross-sectional study. Ann Transl Med. 2021;9(20):1567. doi:10.21037/atm-21-4928
   PubMed Web of Science ®Google Scholar
• Cappellacci F, Canu GL, Lai ML, et al. Association between Hashimoto thyroiditis and differentiated thyroid cancer: a single-center experience. Front Oncol. 2022;12:959595. doi:10.3389/fonc.2022.959595
   PubMed Web of Science ®Google Scholar
• Guan H, de Morais NS, Stuart J, et al. Discordance of serological and sonographic markers for Hashimoto’s thyroiditis with gold standard histopathology. Eur J Endocrinol. 2019;181(5):539–544. doi:10.1530/EJE-19-0424
   PubMed Web of Science ®Google Scholar
• Wu G, Zou D, Cai H, et al. Ultrasonography in the diagnosis of Hashimoto’s thyroiditis. Front Biosci. 2016;21:1006–1012. doi:10.2741/4437
   Web of Science ®Google Scholar
• Ralli M, Angeletti D, Fiore M, et al. Hashimoto’s thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev. 2020;19(10):102649. doi:10.1016/j.autrev.2020.102649
   PubMed Web of Science ®Google Scholar
• Slowinska-Klencka D, Klencki M, Wojtaszek-Nowicka M, et al. Validation of four thyroid ultrasound risk stratification systems in patients with Hashimoto’s thyroiditis; impact of changes in the threshold for nodule’s shape criterion. Cancers. 2021;13:19. doi:10.3390/cancers13194900
   Web of Science ®Google Scholar
• Gao L, Xi X, Jiang Y, et al. Comparison among TIRADS (ACR TI-RADS and KWAK- TI-RADS) and 2015 ATA Guidelines in the diagnostic efficiency of thyroid nodules. Endocrine. 2019;64(1):90–96. doi:10.1007/s12020-019-01843-x
   PubMed Web of Science ®Google Scholar
• Ha EJ, Na DG, Moon WJ, et al. Diagnostic performance of ultrasound-based risk-stratification systems for thyroid nodules: comparison of the 2015 American thyroid association guidelines with the 2016 Korean Thyroid Association/Korean Society of Thyroid Radiology and 2017 American College of Radiology Guidelines. Thyroid. 2018;28(11):1532–1537. doi:10.1089/thy.2018.0094
   PubMed Web of Science ®Google Scholar
• Xu T, Wu Y, Wu RX, et al. Validation and comparison of three newly-released Thyroid Imaging Reporting and Data Systems for cancer risk determination. Endocrine. 2019;64(2):299–307. doi:10.1007/s12020-018-1817-8
   PubMed Web of Science ®Google Scholar
• Xu T, Gu JY, Ye XH, et al. Thyroid nodule sizes influence the diagnostic performance of TIRADS and ultrasound patterns of 2015 ATA guidelines: a multicenter retrospective study. Sci Rep. 2017;7:43183. doi:10.1038/srep43183
   PubMed Web of Science ®Google Scholar
• Wu XL, Du JR, Wang H, et al. Comparison and preliminary discussion of the reasons for the differences in diagnostic performance and unnecessary FNA biopsies between the ACR TIRADS and 2015 ATA guidelines. Endocrine. 2019;65(1):121–131. doi:10.1007/s12020-019-01886-0
   PubMed Web of Science ®Google Scholar
• Middleton WD, Teefey SA, Reading CC, et al. Comparison of performance characteristics of American College of Radiology TI-RADS, Korean Society of Thyroid Radiology TIRADS, and American Thyroid Association Guidelines. AJR Am J Roentgenol. 2018;210(5):1148–1154. doi:10.2214/AJR.17.18822
   PubMed Web of Science ®Google Scholar
• Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017;27(11):1341–1346. doi:10.1089/thy.2017.0500
   PubMed Web of Science ®Google Scholar
• Grani G, Carbotta G, Nesca A, et al. A comprehensive score to diagnose Hashimoto’s thyroiditis: a proposal. Endocrine. 2015;49(2):361–365. doi:10.1007/s12020-014-0441-5
   PubMed Web of Science ®Google Scholar
• Frates MC, Benson CB, Charboneau JW, et al. Management of thyroid nodules detected at US: society of Radiologists in Ultrasound consensus conference statement. Radiology. 2005;237(3):794–800. doi:10.1148/radiol.2373050220
   PubMed Web of Science ®Google Scholar
• Kim DW, Choo HJ, Park JS, et al. Ultrasonography-guided fine-needle aspiration cytology for thyroid nodules: an emphasis on one-sampling and biopsy techniques. Diagn Cytopathol. 2012;40(Suppl 1):E48–E54. doi:10.1002/dc.21669
   PubMedGoogle Scholar
• Gao Y, Qu N, Zhang L, et al. Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma. Tumour Biol. 2016;37(6):7453–7459. doi:10.1007/s13277-015-4535-3
   PubMedGoogle Scholar
• Wang D, Du LY, Sun JW, et al. Evaluation of thyroid nodules with coexistent Hashimoto’s thyroiditis according to various ultrasound-based risk stratification systems: a retrospective research. Eur J Radiol. 2020;131:109059. doi:10.1016/j.ejrad.2020.109059
   PubMed Web of Science ®Google Scholar
• Wang Z, Lin Y, Jiang Y, et al. The associations between thyroid-related hormones and the risk of thyroid cancer: an overall and dose-response meta-analysis. Front Endocrinol. 2022;13:992566. doi:10.3389/fendo.2022.992566
   PubMed Web of Science ®Google Scholar
• Liang L, Zheng XC, Hu MJ, et al. Association of benign thyroid diseases with thyroid cancer risk: a meta-analysis of prospective observational studies. J Endocrinol Invest. 2019;42(6):673–685. doi:10.1007/s40618-018-0968-z
   PubMed Web of Science ®Google Scholar
• Huang H, Rusiecki J, Zhao N, et al. Thyroid-stimulating hormone, thyroid hormones, and risk of papillary thyroid cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2017;26(8):1209–1218. doi:10.1158/1055-9965
   PubMed Web of Science ®Google Scholar
• Gul K, Ozdemir D, Dirikoc A, et al. Are endogenously lower serum thyroid hormones new predictors for thyroid malignancy in addition to higher serum thyrotropin? Endocrine. 2010;37(2):253–260. doi:10.1007/s12020-010-9316-6
   PubMed Web of Science ®Google Scholar
• Jonklaas J, Nsouli-Maktabi H, Soldin SJ. Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer. Thyroid. 2008;18(9):943–952. doi:10.1089/thy.2008.0061
   PubMed Web of Science ®Google Scholar
• Wang X, Jiang F, Chen W, et al. The association between circulating trans fatty acids and thyroid function measures in U.S. adults. Front Endocrinol. 2022;13:928730. doi:10.3389/fendo.2022.928730
   PubMed Web of Science ®Google Scholar
• Külz M, Fellner S, Rocktäschel J, et al. Dubiously increased FT4 and FT3 levels in clinically euthyroid patients: clinical finding or analytical pitfall? Clin Chem Lab Med. 2022;60(6):877–885. doi:10.1515/cclm-2021-1211
   PubMed Web of Science ®Google Scholar
• Fiore E, Vitti P. Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease. J Clin Endocrinol Metab. 2012;97(4):1134–1145. doi:10.1210/jc.2011-2735
   PubMed Web of Science ®Google Scholar
• Song YS, Kim MJ, Sun HJ, et al. Aberrant thyroid-stimulating hormone receptor signaling increases VEGF-A and CXCL8 secretion of thyroid cancer cells, contributing to angiogenesis and tumor growth. Clin Cancer Res. 2019;25(1):414–425. doi:10.1158/1078-0432.CCR-18-0663
   PubMed Web of Science ®Google Scholar
• Hovens GC, Stokkel MP, Kievit J, et al. Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer. J Clin Endocrinol Metab. 2007;92(7):2610–2615. doi:10.1210/jc.2006-2566
   PubMed Web of Science ®Google Scholar
• Wu X, Lun Y, Jiang H, et al. Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer. Endocrine. 2014;46(3):554–560. doi:10.1007/s12020-013-0121-x
   PubMed Web of Science ®Google Scholar
• Spencer CA. Clinical review: clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab. 2011;96(12):3615–3627. doi:10.1210/jc.2011-1740
   PubMed Web of Science ®Google Scholar
• Park M, Park SH, Kim EK, et al. Heterogeneous echogenicity of the underlying thyroid parenchyma: how does this affect the analysis of a thyroid nodule? BMC Cancer. 2013;13:550. doi:10.1186/1471-2407-13-550
   PubMed Web of Science ®Google Scholar